Meeting
2022 ASCO Annual Meeting
The tumor microenvironment and immune infiltration landscape of KRAS mutant pancreatic ductal adenocarcinomas (PDAC) compared to colorectal adenocarcinomas (CRC).
Authors
Emil Lou
Masonic Cancer Center/ University of Minnesota School of Medicine, Minneapolis, MN
Emil Lou , Joanne Xiu , Yasmine Baca , Phillip Walker , Gulam Abbas Manji , Sepideh Gholami , Anwaar Saeed , Philip Agop Philip , Ajay Prakash , Igor A. Astsaturov , Greg Botta , Laith I. Abushahin , Davendra Sohal , Heinz-Josef Lenz , Anthony Frank Shields , Chadi Nabhan , Wafik S. El-Deiry , Andreas Seeber , Wolfgang Michael Korn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4142)
DOI
10.1200/JCO.2022.40.16_suppl.4142
Abstract #
4142
Poster Bd #
127
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomics and transcriptomics of pancreatic adenosquamous carcinoma.
First Author: Brooke Elizabeth Kania
Poster
2023 ASCO Annual Meeting
Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome.
First Author: Bach Ardalan